KATIE GREENWOOD to Antibodies, Monoclonal
This is a "connection" page, showing publications KATIE GREENWOOD has written about Antibodies, Monoclonal.
Connection Strength
0.796
-
The safety of dinutuximab for the treatment of pediatric patients with high-risk neuroblastoma. Expert Opin Drug Saf. 2018 Dec; 17(12):1257-1262.
Score: 0.415
-
Dinutuximab for the treatment of pediatric patients with neuroblastoma. Drugs Today (Barc). 2017 Sep; 53(9):469-476.
Score: 0.381